| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |